Icade, FR0000035081

Icade consensus picture on Euronext, analysts watch the French real estate stock

Published on 06/30/2026 at 12:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Icade opens the week with a clear analyst and consensus profile on Euronext Paris, as investors track the French office and healthcare property specialist in a cautious real estate market.

Icade, FR0000035081, Illustration mit AI erstellt.
Icade, FR0000035081, Illustration mit AI erstellt.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 12:55.

Icade (FR0000035081) starts this Tuesday with a focus on its analyst consensus on Euronext Paris. The French listed real estate group remains on the radar of equity houses that follow office and healthcare property plays in the domestic market.

How analysts view Icade

Analysts typically assess Icade against other French property players such as Gecina and Klépierre, looking at rental income stability, vacancy rates and leverage metrics. Several banks cover the stock with formal ratings and published price targets that frame the consensus view.

Across these research notes, Icade is often described as a diversified landlord with exposure to office campuses in the Paris region and healthcare real estate through dedicated subsidiaries. The split between these segments, plus services, is a recurring topic in analyst models and valuation approaches.

Consensus metrics and key questions

Consensus data services compile the expectations of covered houses for metrics such as recurring net income, funds from operations and dividend per share. For Icade, these expectations anchor investor discussions on whether the shares reflect the underlying property portfolio and development pipeline.

Rating distributions typically show a mix of Buy, Hold and occasional Sell calls, reflecting differing views on French commercial property fundamentals and interest-rate sensitivity. Target prices cluster around analysts’ net asset value estimates, adjusted for perceived execution risk and capital allocation discipline.

Go deeper

All news and analysis on the Icade shares

Further updates, background pieces and price data on Icade can be found in the dedicated topic section and via the company’s investor relations page.

How Icade earns its money

Icade’s business model centers on owning, developing and managing office and business park properties, primarily around Paris, along with a significant healthcare real estate arm and property development activities for third parties and its own portfolio.

Where the shares trade today

The Icade shares (FR0000035081) trade on Euronext Paris. A current price in euros for 2026-06-30, 12:55 could not be independently verified at this moment, so no specific level is stated here.

Key data on the Icade shares

  • Company: Icade S.A.
  • ISIN: FR0000035081
  • WKN: 402476
  • Ticker: ICAD
  • Trading venue: Euronext Paris
  • Price (as of 2026-06-30, 12:55): not independently verified
  • Market cap: not independently verified (as of 2026-06-30)
  • Sector / industry: Real Estate - Diversified
  • Index membership: not independently verified
  • Next earnings date: not officially scheduled

More on the Icade shares in social media

This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any transaction. Figures and assessments are subject to change and should be cross-checked with original sources before making investment decisions.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | FR0000035081 | ICADE | boerse | 69660054 | bgmi